Form EFFECT Fortress Biotech, Inc.
- Dollar loses steam after weeks-long rally
- '3600 is the New Bull Case': Outflows from Energy and Materials Highest in Several Years - BofA
- Ross Stores (ROST) Collapses 28% After Cutting Guidance, Analyst Says It May Take a Few Quarters Before Shares Can Recover
- They Did It Again: Palo Alto (PANW) Delivers Another Robust Quarter, Analysts Bulled-up
- US Households Own Roughly 1/3 of Global Crypto Market - Goldman Sachs
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
|SECURITIES AND EXCHANGE COMMISSION|
|Washington, D.C. 20549|
|Notice of Effectiveness|
|Effectiveness Date:||December 1, 2021|
|Submission Type:||POS AM|
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Checkpoint Therapeutics to Participate in the H.C. Wainwright Global Investment Conference
- Cantor Fitzgerald Reiterates Overweight Rating on Fortress Biotech (FBIO) on Q1 Report, "Risk-Diversification Remains Attractive "
- VSBLTY REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS
Create E-mail Alert Related CategoriesSEC Filings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!